Fucosylation of other glycans, such as alpha-1 antitrypsin, haptoglobin, transferrin and ceruloplasmin, has been shown to be related to the progression of NAFLD to NASH, and higher concentrations have been observed during NAFLD progression to liver fibrosis [304,305]. The gene discussed is SERPINA1; the disease is metabolic dysfunction-associated steatotic liver disease.